Anti-SOX17, Mouse-Mono(245013)

データシート※最新のデータシートでない場合があります

• 商品コード：MAB1924
• メーカー：RSD
• 包装：100μg
• 価格： ¥101,000
• 在庫：1個

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Kim BK et al. Neurogenic effect of vascular endothelial growth factor during germ layer formation of human embryonic stem cells. FEBS Lett. 2006 Oct;580(25):5869-74
  Kim BK et al
  2006/01/01
  
• 備考：
  human embryonic stem cell-derived definitive endodermal cells
• 参照：
  

• No.： 2
• 文献情報：
  Vallier L et al. Conditional gene expression in human embryonic stem cells. Stem Cells 2007 Jun;25(6):1490-7
  Vallier L et al
  2007/01/01
  
• 備考：
  Species: Human, Application: IHC Fresh, Sample type: Whole Cells
• 参照：
  

• No.： 3
• 文献情報：
  Tesar PJ et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007 Jul;448(7150):196-9
  Tesar PJ et al
  2007/01/01
  
• 備考：
  Species: Mouse, Application: IHC Fresh, Sample type: Whole Cells
• 参照：
  

• No.： 4
• 文献情報：
  Smith JR et al. Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev. Biol. 2008 Jan;313(1):107-17
  Smith JR et al
  2008/01/01
  
• 備考：
  Species: Human, Application: IHC Fresh, Whole Tissue
• 参照：
  

• No.： 5
• 文献情報：
  de Jong J et al. Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications. J. Pathol. 2008 May;215(1):21-30
  de Jong J et al
  2008/01/01
  
• 備考：
  Application: Western Blot, Sample Type: Cell Lysates
• 参照：
  

• No.： 6
• 文献情報：
  Sui L et al. FGF signaling via MAPK is required early and improves Activin A-induced definitive endoderm formation from human embryonic stem cells. Biochem. Biophys. Res. Commun. 2012 Sep;426(3):380-5
  Sui L et al
  2012/01/01
  
• 備考：
  Application: ICC, Sample Type: Whole Cells
• 参照：
  

• No.： 7
• 文献情報：
  Thatava T et al. Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Mol. Ther. 2013 Jan;21(1):228-39
  Thatava T et al
  2013/01/01
  
• 備考：
  Application: Flow Cytometry,IHC Fresh, Sample Type: whole cells
• 参照：
  

• No.： 8
• 文献情報：
  Yu JS et al. PI3K/mTORC2 regulates TGF-β/Activin signalling by modulating Smad2/3 activity via linker phosphorylation. Nat Commun 2015;6:7212
  Yu JS et al
  2015/01/01
  
• 備考：
  Application: IHC Not Specified,Western Blot, Sample Type: Cell Lysates,Whole Cells
• 参照：
  

• No.： 9
• 文献情報：
  Hayer SN et al. Generation of an induced pluripotent stem cell line from a patient with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): HIHCNi003-A. Stem Cell Res 2018 Jul;30:206-209
  Hayer SN et al
  2018/01/01
  
• 備考：
  Species: Human, Applications: ICC
• 参照：
  

• No.： 10
• 文献情報：
  Yu L et al. Low Cell-Matrix Adhesion Reveals Two Subtypes of Human Pluripotent Stem Cells. Stem Cell Reports 2018 Jul;11(1):142-156
  Yu L et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 11
• 文献情報：
  Tandon R et al. Generation of two human isogenic iPSC lines from fetal dermal fibroblasts. Stem Cell Res 2018 12;33:120-124
  Tandon R et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 12
• 文献情報：
  Wang Q et al. Measles vector as a multigene delivery platform facilitating iPSC reprogramming. Gene Ther. 2019 05;26(5):151-164
  Wang Q et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 13
• 文献情報：
  Zhu YJ et al. Generation of an induced pluripotent stem cell line (PUMCHi006-A) derived from a patient with pulmonary arterial hypertension carrying heterozygous c.1339 G > A mutation in PTGIS gene. Stem Cell Res 2020 12;49:102088
  Zhu YJ et al
  2020/01/01
  
• 備考：
  Species: Human, Applications: ICC
• 参照：
  

• No.： 14
• 文献情報：
  Gao X et al. Establishment of human induced pluripotent stem cell line (CPGHi002-A) from a 10-month-old female patient with DDOD syndrome carrying a heterozygous c.1516 C > T mutation in ATP6V1B2. Stem Cell Res 2020 10;48:101986
  Gao X et al
  2020/01/01
  
• 備考：
  Species: Human, Applications: ICC
• 参照：
  

• No.： 15
• 文献情報：
  Ohta E et al. Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson's disease carrying the I2020T mutation in LRRK2. Stem Cell Res 2020 12;49:102073
  Ohta E et al
  2020/01/01
  
• 備考：
  Species: Human, Applications: ICC
• 参照：
  

• No.： 16
• 文献情報：
  Gao X et al. Generation of an iPSC line (GWCMCi002-A) from an X-linked Alport syndrome patient with a hemizygous splicing mutation (NM_000495.4, c. 1517-1 G > T) in the COL4A5 gene. Stem Cell Res 2021 05;53:102388
  Gao X et al
  2021/01/01
  
• 備考：
  Species: Human, Applications: ICC
• 参照：
  

• No.： 17
• 文献情報：
  Gao X et al. Generation of a gene corrected human isogenic iPSC line (CPGHi002-A-1) from a DDOD patient with heterozygous c.1516 C>T mutation in the ATP6V1B2 gene. Stem Cell Res 2021 05;53:102271
  Gao X et al
  2021/01/01
  
• 備考：
  Species: Human, Applications: Flow Cytometry
• 参照：
  

• No.： 18
• 文献情報：
  Fischer I et al. Generation of human induced pluripotent stem cell lines from 2 patients with MIRAGE syndrome. Stem Cell Res 2021 07;54:102417
  Fischer I et al
  2021/01/01
  
• 備考：
  Species: Human, Applications: Flow Cytometry
• 参照：
  

• No.： 19
• 文献情報：
  Li N et al. An induced pluripotent stem cell line (GZHMCi004-A) derived from a fetus with heterozygous G380R mutation in FGFR3 gene causing achondroplasia. Stem Cell Res 2021 05;53:102322
  Li N et al
  2021/01/01
  
• 備考：
  Species: Human, Applications: Flow Cytometry
• 参照：
  

• No.： 20
• 文献情報：
  Jia N et al. Generation of an induced pluripotent stem cell line (OGHFUi001-A) from a type 1 early infantile epileptic encephalopathy with ARX mutation. Stem Cell Res 2021 05;53:102367
  Jia N et al
  2021/01/01
  
• 備考：
  Species: Human, Applications: ICC
• 参照：
  

• No.： 21
• 文献情報：
  Gao X et al. Derivation of an induced pluripotent stem cell line (GWCMCi001-A) from PBMCs of a four-year-old male patient with Immunoglobulin A nephropathy. Stem Cell Res 2020 Dec;50:102123
  Gao X et al
  2020/01/01
  
• 備考：
  Species: Human, Applications: Flow Cytometry
• 参照：
  

• No.： 22
• 文献情報：
  Zhou HM et al. An induced pluripotent stem cell line (SHEHi002-A (5426))from a patient of long QT syndrome type 8 with c.2573G>A mutation in the gene CACNA1C. Stem Cell Res 2020 03;43:101731
  Zhou HM et al
  2020/01/01
  
• 備考：
  Species: Human, Applications: ICC
• 参照：
  

• No.： 23
• 文献情報：
  Li J et al. Generation of a human induced pluripotent stem cell line (CPGHi003-A) from an auditory neuropathy patient with AIFM1 p.R422Q mutation. Stem Cell Res 2021 05;53:102376
  Li J et al
  2021/01/01
  
• 備考：
  Species: Human, Applications: Flow Cytometry
• 参照：
  

• No.： 24
• 文献情報：
  Zheng Z et al. Generation of an induced pluripotent stem cell line (CHFUi001-A) from an osteogenesis imperfecta patient with COL1A2 mutation. Stem Cell Res 2020 Jul;47:101907
  Zheng Z et al
  2020/01/01
  
• 備考：
  Species: Human, Applications: ICC
• 参照：